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SUMMARY 
Levels of protein and activity of several enzymes were determined in different 
portions of the visual system of the human brain. The enzymes studied were total 
cholinesterase (TChE), acetylcholinesterase (ACHE), pseudocholinesterase (ChE), 
choline acetyltransferase (ChAc), monoamine oxidase (MAO), and N-methyltrans- 
ferase (NMT). Brains of 17 patients were obtained at autopsy. The specimens were 
divided into 3 groups. One group consisted of the brains of subjects who were mentally 
normal prior to death. The second group of subjects had been diagnosed as chronic 
schizophrenics and the third had an organic brain syndrome. Each group included 
males and females. Subjects with an organic brain syndrome were significantly older 
than subjects in either of the other two groups. There were no significant differences in 
protein among the 3 groups for most of the visual areas. All enzyme activity was 
expressed per g of protein. TChE, ACHE, and ChE activity varied markedly within the 
visual system, being usually lowest in the optic nerve and highest in the superior colli- 
culus. There were no significant differences in TChE or AChE among the diagnostic 
groups. Unexpectedly, ChE was elevated in some brain areas in the chronic schizo- 
phrenic group. This finding needs further confirmation in a drug free group. ChAc did 
not differ significantly among the 3 diagnostic groups and, in general, was low through- 
out the visual system but highest in the superior colliculus and lateral geniculate. 
MAO activity was not significantly different among the 3 patient groups. Its activity 
in the gray matter was only slightly higher than in the white matter of the visual sys- 
tem. NMT activity was extremely low (about 0.1 ~ the activity of the other enzymes) 
throughout all areas studied and did not differ significantly between areas or diagnostic 
groups. 
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INTRODUCTION 
There is evidence that lateral geniculate neurons of various animals respond to 
acetylcholine, norepinephrine, and serotonin applied iontophoretically 21. The regional 
distribution of the enzymes associated with each of these putative neurotransmitters 
in the visual system has been studied previously, especially in animals. Many investi- 
gators have included portions of the visual system in their analyses of the regional 
brain distribution of some of these enzymes. For example, choline acetyltransferase 
(ChAc, EC 2.3.1.6.)is present in the lateral geniculate nucleus of man and several 
other animals 8,9,12. Both acetylcholinesterase (ACHE, EC 3.1.1.7) and pseudocholin- 
esterase (ChE, EC 3.1.1.8) are also present in portions of the visual system, especially 
the lateral geniculate nucleus1,5,1°,11,18-2°. Monoamine oxidase (MAO, EC 1.4.3.4) 
activity has also been reported3,4, 24. The distribution of N-methyltransferase (NMT) 
activity in the visual system has not been previously studied. 
We have had a unique opportunity to study the gross distribution of several of 
these enzymes in the visual system of patients who prior to death were mentally 
normal, or had chronic schizophrenia or an organic brain syndrome. The data obtain- 
ed indicate that the cholinergic enzymes are significantly elevated in the lateral 
geniculate nucleus and superior colliculus of the visual system of man. 
MATERIALS AND METHODS 
Tissue sources 
Brains were obtained from autopsies performed on patients who died at North- 
ville State Hospital, Detroit General or University Hospital (Ann Arbor). A total of 17 
brains was examined. Eleven were from Northville, 5 from Detroit General and one 
from University Hospital. After death, the body was kept at 4 °C. Autopsies were 
performed within 36 h after death. Most were within 24 h. At autopsy the brain was 
removed and frozen. One to 4 days after death the brain was transferred to a dry ice 
freezer (--50 °C) at the Lafayette Clinic and kept there until 24 h before dissection, 
when it was gradually thawed in a cold room. After dissection, the tissues were either 
homogenized the same day and the homogenates frozen for assay at a later date or the 
tissues were packed in plastic bags and frozen for later homogenization and assay. 
Patient diagnosis 
Three patients (numbers 3, 9, 15) were diagnosed as having an organic brain 
syndrome (OBS). Seven patients were chronic schizophrenics who had been given 
psychotropic drugs recently (1, 2, 4, 10, 11, 12, 13) and one was a chronic schizo- 
phrenic who was drug free (14). The rest were mentally normal prior to death. The 
numbers in parentheses refer to the order in which the brain specimens were accepted 
into the study. All diagnoses were made by the attending psychiatrist and verified by 
review of the records by one of us. 
Drug history 
Four patients (3, 9, 14, 17) were drug free for several months or longer prior to 
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death. Five patients (1, 2, 4, 11, 12) received psychotropic drugs (usually antipsycho- 
tics) within 1 week prior to death. These 5 and all mentally normal patients except 17 
also received various non-psychoactive drugs (e.g., digitoxin, antibiotics) prior to 
death. Most of the drugs were discontinued from 1 week to hours before death. 
Cause of death 
Ten patients (1, 2, 3, 9, 10, 12, 15, 16, 20, 21) died of bronchial pneumonia and/or 
pulmonary embolism. One (11) died of acute peritonitis and perforated gastric ulcer. 
One (13) died of a myocardial infarction and terminal pneumonia. One (4) suffered 
congestive heart failure and one (14) died of an acute myocardial infarction. Another 
(17) suffocated, one (18) died of renal failure, and one (19) died of lung cancer. 
Physical characteristics 
Seven patients (3, 4, 14, 15, 17, 19, 21) were males and 10 (1, 2, 9, 10, 11, 12, 13, 
16, 18, 20) were females. Their ages ranged from 14 to 90 years. Four (13, 16, 19, 20) 
were Negro, the rest Caucasians. 
There were unavoidable delays in obtaining the brains or performing the enzy- 
matic studies. Delays of from 4 days up to 1 year occurred between date of death and 
date of enzyme assay. All tissue was frozen during the interim. 
Chemical assays 
Several assays were performed and standards run. Protein standards were bovine 
serum albumin and Dade protein standard. Rat brain was the standard enzyme source 
for total cholinesterase (TChE), ACHE, ChE, and ChAc activity. Cow caudate nucleus 
and rabbit lung were standards for NMT and cow caudate for MAO activity. 
Protein determination 
Proteins were determined according to the method of Lowry et al. 15 using the 
Folin Cu-EDTA method. Brain homogenates of 10 ~ and l ~ were prepared in glass 
distilled water and 5 ml of Cu-EDTA reagent were added to 1 mg of tissue diluted in 
water (1 ml total). Ten min later 0.5 ml of a 1:1 diluted phenol reagent was added, 
mixed, and after 30 min samples were read at 650 nm in a Beckman spectrophotom- 
eter. 
Acetylcholinesterase and cholinesterase 
TChE was measured using the method of Siakotos et al. z3. This is a radiochem- 
ical method in which acetyl-[1-14C]choline is used as the substrate. The principle of 
the assay is that acetylcholine (ACh) is hydrolyzed and after 10 min the reaction stopped 
by the addition of a strongly acidic cationic exchange resin which binds the unhydro- 
lyzed substrate. TChE activity was measured without any inhibitor. ChE activity was 
measured using the specific AChE inhibitor, BW 284c51 (1:5,-bis-(4-allyldimethyl- 
ammoniumphenyl)pentan-3-onedibromide)at 1 × 10-6Mfinalconcentration, dissolv- 
ed in 0.1 M phosphate buffer. AChE activity was obtained by subtracting the residual 
ChE activity from the TChE. Amberlite CG-120 (Mallinckrodt) mixed with dioxane 
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was used to stop the reaction and bind unhydrolyzed ACh. The reaction mixture 
consisted of 0.1 ml of 0.1 M phosphate buffer, pH 7.4 containing 0.3 M sodium 
chloride and 1 ~ Lubrol WX as a detergent, the brain enzyme source (0.1 ml) and 
substrate (0.1 ml). Total volume was 0.3 ml. Final substrate concentration was 1 × 
10 -3 M [14C]ACh. The buffer, inhibitor and enzyme source were added to centrifuge 
tubes and the racks placed in a 37.5 °C water bath. The substrate was then added, 
mixed and the tubes incubated for 10 rain. Nonenzymatic hydrolysis of labeled sub- 
strate was measured using 0.1 ml distilled water or boiled enzyme source when possible. 
Rat brain TChE was run as a standard with each assay. The reaction was stopped by 
the addition of  the resin-dioxane mixture. Additional dioxane was then added, the 
tubes capped, mixed, and centrifuged at 3000 rev./min for 5 min. One-half (5 ml) of 
the supernatant was transferred to a scintillation counting vial to which was added 
10 ml o f a  dioxane-based scintillation cocktail (Aquafluor). Samples were counted in a 
Beckman LS-150 scintillation counter. All enzyme values were expressed in #mole 
ACh hydrolyzed/g of brain protein/min. 
Choline acetyltransferase 
ChAc activity was assayed using a combination of the methods of McCaman 
and Hunt 17 and Schrier and Shuster2L A 10 ~ homogenate of the various brain areas 
was used, 1 mg of tissue being assayed. The 0.1 ml incubation mix consisted of NaC1, 
3 × 10 -1 M; choline chloride, 1 × 10 -2 M; physostigmine, 2 × 10 -4 M; MgSO4, 2 × 
10 -2 M; 0.05~o serum albumin; phosphate buffer, 0.08 M, pH 7.4; and acetyl CoA, 
6.2 × 10 -4 M. The acetyl CoA was a mixture of labeled acetyl-[1-14C]CoA (New 
England Nuclear) and cold acetyl CoA (Sigma) in such proportion that 0.1 ml of the 
incubation mix contained approximately 20,000 counts/min. After 30 min incubation 
at 37.5 °C, the tubes were plunged into boiling water for 5 min to stop the reaction. 
Incubation mixtures were then applied to the top of prewashed Dowex 1 × 8 C1- 
(BioRad) columns, 8 cm high, prepared from diSPo pipets plugged with glass wool. 
Three consecutive 0.5 ml water washes were applied to the column and the effluent 
collected directly into scintillation vials. Fifteen ml of a dioxane mixture (8 g PPO, 0.1 
g POPOP, 110 g naphthalene, 1 liter dioxane) were added to each vial and the samples 
counted in a Beckman LS-200 liquid scintillation counter. Enzyme activity was ex- 
pressed as #mole ACh/g protein/min. 
Monoamine oxidase 
MAO activity was measured by the methods of Ho et al. x3 and Wurtman and 
Axelrod 25. The method is based on the oxidation of [14C]tryptamine by MAO to form 
the corresponding aldehyde and further oxidation by aldehyde dehydrogenase to 
i ndoleacetic acid (IAA). A 0.1 ml aliquot of a 10 ~ brain homogenate (10 mg), 0.1 ml 
of [14C]tryptamine, 2.4 × 10 -4 M, and 1 ml of a 0.5 M NazHPO4 buffer, pH 7.4, for a 
total 1.2 ml final assay volume was used. Final substrate concentration was 2 × 10 -5 
M. Tissue blanks were prepared by substituting boiled enzyme source. Standards in- 
cluded cow caudate and occasionally rat brain homogenate. The enzyme mixture was 
incubated for 30 min at 37.5 °C and reaction stopped with 0.5 ml 2 N HCI and [14C]- 
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I A A  extracted with 5 ml ether. After  centrifuging at 2500 rev./min for 5 min the tubes 
were frozen and the ether layer removed. Three ml o f  the ether layer were added to 
scintillation vials with 10 ml toluene scintillation solution and heated at 45 °C to 
volatilize the ether. The entire procedure was carried out  in a well ventilated hood.  All 
enzyme activity was expressed in #mole  o f  t ryptamine oxidized/g o f  protein/min. 
N-methyl transf  erase 
N M T  was assayed via the method of  Mandell et al. 16. This is a radiochemical  
method based on the methylat ion o f  t ryptamine to labeled N-methyl  tryptamine.  The 
method is similar to that  described by Axelrod 2 except that  toluene rather than iso- 
amyl alcohol is used to extract the methylated tryptamine.  Blanks were prepared by 
boiling the enzyme source o f  the same concentra t ion as that  used in the assay. Ten 
percent cow caudate  or  rabbit  lung homogenized in cold distilled water was used as a 




The age (mean ± S.E.) o f  the mentally normal  group (N = 6) was 53.3 i 9.9, 
that  o f  the chronic schizophrenic patients (N = 8) was 62.2 ± 4.9, and that  o f  the or- 
ganic brain syndrome group (N = 3) 83.3 ± 5.2 years. Using a group compar ison 
' t '  test the age differences between the normals  and the chronic schizophrenics was not  
statistically significant, but  the organic brain syndrome group differed significantly 
TABLE I 
PROTEIN CONCENTRATION OF MENTALLY NORMAL, CHRONIC SCHIZOPHRENIC AND ORGANIC BRAIN SYN- 
DROME PATIENTS 
The numbers in parentheses after mean 4- S.E. represent the number of subjects in each group. 
Brain area Mean 4- S.E. (g prot/g wet weight} 
Mentally normal Chronic schizophrenic Organic brain syndrome 
(MN) (CS) (OBS) 
Optic nerve 0.104 i 0.007 (5) 0.099 ± 0.016 (5) 0.068 4- 0.006 (3)** 
Chiasm 0.105 4- 0.003 (6) 0.100 -I- 0.011 (2) 0.081 4- 0 (1) 
Optic tract 0.102 4- 0.004 (6) 0.107 4- 0.011 (5) 0.104 4- 0.015 (3) 
Lateral geniculate 0.106 4- 0.003 (6) 0.131 4- 0.025 (5) 0.098 4- 0.008 (3) 
Optic radiation 0.105 4- 0.004 (6) 0.116 4- 0.005 (5) 0.108 4- 0 (1) 
Occipital cortex 0.090 4- 0.006 (6) 0.102 ± 0.011 (5) 0.093 4- 0.007 (2) 
Superior colliculus 0.099 4- 0.006 (5) 0.114 4- 0.018 (6) 0.101 4- 0.003 (3) 
In this and all subsequent tables the symbols are: 
* Significant at the 0.05 level (group comparison of MN vs. CS or MN vs. OBS). 
** Significant at the 0.01 level (group comparison of MN vs. CS or MN vs. OBS). 
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TABLE II 
TOTAL CHOLINESTERASE ACTIVITY OF MENTALLY NORMAL, CHRONIC SCHIZOPHRENIC AND ORGANIC 
BRAIN SYNDROME PATIENTS 
Brain area Mean 4- S.E. (ftmole/g prot/min) 
Mentally normal Chronic schizophrenic Organic brain syndrome 
(MAr) (CS) (OBS) 
Optic nerve 2.9 i 0.2 (5) 3.8 4- 1.4 (5) 5.1 4- 2.1 (3) 
Chiasm 8.8 4- 2.0 (6) 4.4 4- 2.2 (2) 8.0 4- 0 (1) 
Optic tract 13.9 -- 5.7 (6) 5.5 4- 1.6 (5) 8.1 4- 3.5 (3) 
Lateral geniculate 38.7 4- 4.0 (6) 39.1 4- 10.3 (5) 57.1 ~: 29.0 (3) 
Optic radiation 4.7 ~ 1.0 (6) 3.3 4- 0.8 (5) 4.1 4- 0 (1) 
Occipital cortex 8.1 4- 1.9 (6) 9.5 4- 1.4 (5) 4.9 4- 1.9 (2) 
Superior colliculus 76.3 4- 10.1 (5) 76.8 4- 9.1 (6) 62.2 4- 15.3 (3) 
f rom both  the mental ly  no rma l  (P  < 0.03) and the chronic  schizophrenic  pat ients  
(P  < 0.02). 
Protein 
The concent ra t ion  o f  g pro te in /g  o f  wet weight o f  bra in  tissue among  the 
var ious  areas  o f  the visual system was approx ima te ly  1 0 ~ .  There  were no great  
differences between the opt ic  nerve, chiasm, opt ic  tract,  la teral  geniculate and  opt ic  
radia t ion .  On the o ther  hand,  the occipital  cor tex and super ior  colliculus had  slightly 
lower pro te in  values in the mental ly  normal  group.  There  were no significant differ- 
ences between the 3 diagnost ic  categories  o f  menta l ly  normal ,  chronic  schizophrenic  
or  organic  bra in  syndrome pat ients  in any o f  the areas  s tudied except  that  there  was a 
significantly lower pro te in  concent ra t ion  (P  < 0.01) in the opt ic  nerve o f  the 3 pat ients  
with an organic  bra in  syndrome.  Two of  these pat ients  dur ing  life had  reasonable  
TABLE III 
ACETYLCHOLINESTERASE ACTIVITY OF MENTALLY NORMAL~ CHRONIC SCHIZOPHRENIC AND ORGANIC 
BRAIN SYNDROME PATIENTS 
Brain area Mean 4- S.E. (izmole/g prot/min) 
Mentally normal Chronic schizophrenic Organic brain syndrome 
(MN) (CS) ( 0 BS) 
Optic nerve 1.7 i 0.1 (5) 2.4 ± 0.8 (5) 5.3 4- 3.5 (2) 
Chiasm 7.2 4- 1.9 (6) 3.0 4- 1.6 (2) 6.9 4- 0 (I) 
Optic tract 12.7 4- 5.4 (6) 3.8 4- 1.1 (5) 7.7 4- 5.8 (2) 
Lateral geniculate 36.2 4- 3.9 (6) 27.8 4- 8.0 (5) 65.3 4- 20.8 (2) 
Optic radiation 3.2 4- 0.7 (6) 1.9 4- 0.5 (5) 4.1 4- 0 (1) 
Occipital cortex 6.8 + 1.6 (6) 6.9 4- 1.1 (5) 4.4 4- 2.4 (2) 
Superior colliculus 71.6 4- 9.5 (5) 60.4 4- 7.9 (6) 51.2 4- 31.1 (2) 
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TABLE IV 
PSEUDOCHOLINESTERASE ACTIVITY OF MENTALLY NORMAL~ CHRONIC SCHIZOPHRENIC AND ORGANIC BRAIN 
SYNDROME PATIENTS 
Brain area Mean -4- S.E. (l~mole/g prot/min) 
Mentally normal Chronic schizophrenic Organic brain syndrome 
(MN) (CS) (OBS) 
Optic nerve 1.1 -4- 0.2 (5) 1.7 4- 0.7 (5) 0.2 :k 0.2 (2) 
Chiasm 1.6 -4- 0.2 (6) 1.5 -4- 0.7 (2) 1.1 -4- 0 (1) 
Optic tract 1.2 -4- 0.4 (6) 1.9 -+- 0.6 (5) 0.2 -4- 0.2 (2) 
Lateral geniculate 2.5 -4- 0.4 (6) 7.8 -4- 2.1 * (5) 13.6 -4- 12.5 (2) 
Optic radiation 1.4.4. 0.3 (6) 1.4 :z 0.4 (5) 0.1 :k: 0 (1) 
Occipital cortex 1.3 4- 0.3 (6) 2.5 ± 0.5 (5) 0.5 ~: 0.5 (2) 
Superior colliculus 4.6 4- 0.5 (5) 16.4 4- 1.7"* (6) 7.8 :~ 5.2 (2) 
vis ion for  their  age;  the th i rd  had  p o o r  vision but  was not  blind. The da t a  are l isted in 
Table  I. 
Total  cholinesterase activity 
Using [14C]ACh as substrate ,  ma rked  regional  differences in T C h E  act ivi ty were 
found  in the visual system (Table  II).  The  lowest  act ivi ty  (mean 4- S.E.) was present  
in the opt ic  nerve (2.9 ± 0 .2/~mole/g p ro te in /min)  and  the highest  act ivi ty in the supe- 
r ior  coll iculus (76.3 4- 10 .1 / tmole /g  pro te in / ra in)  for  the menta l ly  normal .  The  opt ic  
ch iasm also had  more  TChE  act ivi ty than  the opt ic  nerve. Both  the opt ic  r ad ia t ion  and  
occipi ta l  cor tex had  relat ively low activity.  On the o ther  hand,  the super ior  coll iculus 
and  lateral  geniculate had  an  apprec iab le  a m o u n t  o f  T C h E  activity.  There  were no  
significant differences between the menta l ly  normal ,  chronic  schizophrenic,  and  organic  
b ra in  syndrome  patients .  
TABLE V 
CHOLINE ACETYLTRANSFERASE ACTIVITY OF MENTALLY NORMAL, CHRONIC SCHIZOPHRENIC AND ORGANIC 
BRAIN SYNDROME PATIENTS 
Brain area Mean 4- S.E. (l~mole/g prot/min) 
Mentally normal Chronic schizophrenic Organic brain syr, drome 
(MN) (CS) (OBS) 
Optic nerve 0.027 ± 0.008 (5) 0.022 ± 0.008 (4) 0.023 -+- 0.006 (3) 
Chiasm 0.058 ± 0.014 (6) - -  0.044 ± 0 (1) 
Optic tract 0.055 -4- 0.022 (6) 0.023 -4- 0.008 (5) 0.041 -4- 0.014 (3) 
Lateral geniculate 0.133 -4- 0.047 (6) 0.071 4- 0.021 (5) 0.495 -4- 0.438 (3) 
Optic radiation 0.030 -4- 0.009 (6) 0.019 -4- 0.005 (5) 0.029 -4- 0 (1) 
Occipital cortex 0.051 -4- 0.011 (6) 0.037 -4- 0.012 (5) 0.004 4- 0.002 (2) 
Superior colliculus 0.101 -4- 0.047 (5) 0.120 -4- 0.028 (5) 0.103 -4- 0.060 (3) 
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A cetylcholinesterase activity 
Using the specific A C h E  inhibitor, BW 284c51, and subtracting the residual 
ChE activity, an estimate o f  A C h E  activity was obtained. It  can be seen, as has been 
described previously for brain tissue, that  most  of  the cholinesterase activity was due to 
A C h E  14. The qualitative distribution o f  A C h E  activity in the visual system was similar 
to that o f  T C h E  with no significant differences among  the patient groups (compare 
Tables II  and III). 
Pseudocholinesterase activity 
ChE activity did not  show as striking regional differences as were seen with 
A C h E  (Table IV). The lateral geniculate and superior colliculus tended to have more  
activity than the other visual areas. There were no significant differences between 
mentally normal  and organic brain syndrome patients. Surprisingly, ChE activity was 
enhanced compared  to the mentally normal  group in the lateral geniculate and supe- 
rior colliculus of  the chronic schizophrenic patients. These differences were significant 
(P < 0.05), When the data were normalized, that  is, expressed as a fraction of  the 
ChE standard for each assay, the differences were still statistically significant for both 
the lateral geniculate and the superior colliculus (P < 0.01). It should be remembered 
that most  o f  the schizophrenic patients prior to death were on neuroleptic medication 
(see Discussion). 
Choline acetyltransferase activity 
The same difference between optic nerve, chiasm and optic tract that  was observ- 
ed with A C h E  activity was also present with the distribution o f  ChAc. In  general, optic 
radiation and occipital cortex also showed low levels of  activity. A similar pattern o f  
distribution o f  ChAc, being highest in the lateral geniculate and superior colliculus, 
was seen among  the mentally normal,  chronic schizophrenic and organic brain syn- 
TABLE VI 
MONOAMINE OXIDASE ACTIVITY OF MENTALLY NORMAL~ CHRONIC SCHIZOPHRENIC AND ORGANIC BRAIN 
SYNDROME PATIENTS 
Expressed as a fraction of cow caudate standard = 1.000. Mean 4- S.E. cow caudate MAO activity 
was 0.092 ~ 0.018/~mole/g of tissue/min. 
Brail~ area Mean ~ S.E. 
Mentally normal Chronic schizophrenic Organic brain syttdrome 
(MN) (CS) (OBS) 
Optic nerve 0.348 ± 0.018 (4) 0.507 ± 0.118 (4) 0.535 i 0.220 (3) 
Chiasm 0.282 ± 0.036 13) 0.608 ± 0.237 (2) 0.878 4- 0 (1) 
Optic tract 0.363 i 0.086 (4) 0.367 i 0.028 (5) 0.459 ~ 0.212 (3) 
Lateral geniculate 0.471 4- 0.072 (4) 0.480 4- 0.029 (5) 0.424 ~- 0.275 (3) 
Optic radiation 0.192 ~ 0.015 (4) 0.236 ~ 0.062 (4) 0.400 ± 0 (1) 
Occipital cortex 0.454 ± 0.044 (4) 0.439 ~ 0.088 (5) 0.297 ~ 0.297 (2) 
Superior colliculus 0.639 ± 0.080 (3) 0.604 i 0.146 (6) 0.676 i 0.235 (3) 
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drome patients. There were no significant differences between these subgroups where 
an N of 3 or more was compared (see Table V). 
Monoamine oxidase activity 
In view of  the fact that there was considerable variation in our standards for MAO 
activity, all data were expressed as a fraction of 1.000 for cow caudate nucleus standard 
run simultaneously. It can be seen in the mentally normal group that the differences in 
distribution of  MAO between various visual areas were not as striking as with TChE. 
The superior colliculus tended to have the greatest activity with the lateral geniculate 
next. Likewise, the occipital cortex showed somewhat similar activity. White matter 
areas showed less activity but still appreciable amounts, as shown in Table VI. There 
were no significant differences between the mentally normal, chronic schizophrenic, 
and organic brain syndrome patients. In the latter two groups the activity in the optic 
chiasm was especially high but, in view of the small N, was not tested for statistical 
significance. 
N-methyltransferase activity 
N M T  activity was determined using tryptamine as the substrate. There were no 
significant gray-white differences in any of the patient groups. Enzyme activity varied 
from a low of 0.252 to a high of 0.810 nmole/g protein/min. Of special importance is 
the fact that N M T  activity was extremely low throughout the visual system, approx- 
imately 0.1 ~ the activity of  the other enzymes. 
DISCUSSION 
There are many objections to this study. One is faced with the practical consider- 
ation of patients dying from different causes at different times. The time of death to 
the time of  autopsy is a variable which could not be controlled under most circum- 
stances because of the need to obtain family permission, autopsy scheduling, etc. 
Furthermore, once an autopsy was performed all brains were frozen until subsequent 
thawing for dissection and regional assay. Thus, the question of  enzyme stability 
with freezing and thawing becomes paramount. Another variable was the fact that the 
chronic schizophrenic patients in general had various neuroleptic agents given until 
shortly before their terminal illness, and all patient groups were given various medica- 
tions including antibiotics, cardiovascular drugs, etc. until just before death. In view of 
these many variables that could not be controlled, the data obtained are surprising 
because of their consistency with known literature on the distribution of  these enzymes 
in the visual system of  animals where such variables can be controlled ~. 
No significant differences in TChE were seen across patient categories. An 
especially interesting finding was that optic nerve TChE activity was much lower than 
that in the optic chiasm and optic tract. The present findings in man have previously 
been observed in animals 11. A somewhat surprising finding was that the chronic 
schizophrenic patients may have more ChE activity in the lateral geniculate and 
superior colliculus. This may be related to the fact that these patients were on neuro- 
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leptic medication prior to death. It is well known that neuroleptic agents in low con- 
centrations tend to activate ChE activity 7. One chronic schizophrenic patient (14) was 
drug free. ChE in his lateral geniculate was 1.1/zmole/g protein/min and 10.7 #mole/g 
protein/min in his superior colliculus. His lateral geniculate value is less than the mean 
for all patient groups. His superior colliculus value is higher than the mean of  the 
normal and organic brain syndrome groups but less than that of the other chronic 
schizophrenics. Thus, the data of  this case both support and deny the hypothesis that 
the increase in ChE activity is due to neuroleptic medication. 
The qualitative distribution of ChAc activity in the visual system was similar to 
that of TChE and AChE activity. These findings again emphasize an important role of 
the cholinergic system in the human lateral geniculate and superior colliculus. These 
data are in complete harmony with data in the literature on the distribution of these 
enzymes in the visual system of animals 6. 
There was no significant difference in MAO activity among the 3 patient 
groups. While there was a difference in the distribution of MAO in white v e r s u s  gray 
matter, all areas of  the visual system showed considerably less activity than the cow 
caudate nucleus standard. The highest values obtained were in the superior colliculus 
and lowest in the optic radiation of the normal group. In general, nuclear masses such 
as the superior colliculus and lateral geniculate tended to have somewhat elevated 
activity compared to the optic nerve, optic tract and radiation. Of all the enzymes 
studied, NMT activity was by far the lowest. In general, it was slightly above boiled 
blanks. It may be that the extremely low levels of N M T  activity can be in part related 
to the fact that this enzyme, when obtained from rabbit lung, is more likely to be 
destroyed by freezing (unpublished observation, 1972) than the other enzymes such as 
cholinesterase 10. 
It is concluded that the cholinergic enzymes are present in relatively large 
amounts in the lateral geniculate and superior colliculus of man, irrespective of psychi- 
atric status. If enzyme activity is any indication of functional importance, ACh prob- 
ably plays an important role in these areas of the human visual system. 
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